Skip to main content

Possible Factors Responsible for Adverse Effects of Long-Term L-Dopa Therapy: Simultaneous Determinations of Dopamine Parameters in Rats

  • Chapter
Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 38A))

  • 15 Accesses

Abstract

After initial benefit, many adverse effects, i.e., “wearing-off”, “on-off”, or dyskinesia develop following long-term l-dopa therapy. Especially, causes of “wearing-off”, which is the most common adverse effect, are proposed to be 1) alterations of l-dopa absorption from the gut, 2) a reduction in l-dopa transport across the blood-brain barrier, 3) changes in dopamine (DA) distribution and metabolism in the CNS, and 4) modification of striatal DA receptor activity.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D. B. Calne, P. F. Teychenne, and R. F. Pfeiffer, in: “Parkinson’s Disease; Neurophysiological, Clinical and Related Aspects,” F.A. Messiha and A. Kenny, eds., Plenum Press, New York (1977).

    Google Scholar 

  2. I. A. Hendry and L. L. Iversen, Effect of nerve growth factor and its antiserum on tyrosine hydroxylase activity in mouse superior cervial sympathetic ganglion., Brain research 29: 159 (1971).

    Article  PubMed  CAS  Google Scholar 

  3. G. Fabbrini, M. M. Mouradian, J. L. Juncos, J. Schlegel, E. Mohr, and T. N. Chase, Motor fluctuations in Parkinson’s disease: central pathophysiological mechanisms, part I., Ann. Neurol. 24: 366 (1988).

    Article  PubMed  CAS  Google Scholar 

  4. G. A. Lyles and B. A. Collingham, Short-and long-term effects of 1-dopa treatment upon monoamine oxydase: a comparative study in several rat tissues., Eur. J. Pharmacol. 61: 363 (1980).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Murata, M., Yoneda, K., Kanazawa, I. (1990). Possible Factors Responsible for Adverse Effects of Long-Term L-Dopa Therapy: Simultaneous Determinations of Dopamine Parameters in Rats. In: Nagatsu, T., Fisher, A., Yoshida, M. (eds) Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 38A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5844-2_102

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5844-2_102

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5846-6

  • Online ISBN: 978-1-4684-5844-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics